Multinational Diversification and Pharmaceutical Units Performance:  Evidence from Indian Firms by Sridharan, Perumal
Ushus J B Mgt 12, 3 (2013), 77-87 
ISSN 0975-3311│ doi: 10.12725/ujbm.24.5  
77 
 
Multinational Diversification and 
Pharmaceutical Units Performance:  
Evidence from Indian Firms 
Perumal Sridharan * 
Abstract 
This paper examines the performance of select Foreign 
Direct Invested (FDI) assisted pharmaceutical units in 
India for the period from 1st April 1999 to 31st March 
2008.  The dataset has been retrieved from CMIE Prowess 
database and Organization of Pharmaceuticals Producers 
of India (OPPI) for 23 FDI assisted pharmaceutical units 
and evaluated through the following ratios Capital 
Structure Ratios, Liquidity Ratios, Profitability Ratios, Du 
Pont Analysis and Return on Investment. Our findings 
suggest, that the capital has been efficiently used in 
gearing profits, but there was a slight decline in return on 
equity due to over utilization of outsider‟s capital it was 
the major reason for showing negative effects.  But, all the 
sample units show a galloping trend during the study 
period.  The liquidity position and short-term solvency 
positions have improved, because of this the sales have 
increased, the leverage effects was not found favourable 
for certain units.  Finally, our study suggests that the 
mark of FDI assisted pharmaceutical units for different 
ratios report a positive direction throughout the study 
and provoked the strength of Indian economy for the 
future. 
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Introduction 
The tremendous growth of Foreign Direct Investment (FDI) flows is 
well documented in literature for both developing and developed 
countries.  Over the last couple of decade foreign direct investment 
have grown at least twice as rapidly as trade Lipsey (2000). As 
there is shortage of capital in the developed countries, which need 
capital for their development process, the marginal productivity of 
capital is higher in developing countries. On the other hand, 
investors in developed world seek high returns for their capital.  
Hence there is a mutual benefit in the international movement of 
capital. In the current international economic setup, the countries 
progress towards globalization, liberalization and private foreign 
capital is indispensable. Loans (commercial bank lending‟s and 
bonds issued by companies) and Equities (direct and portfolio 
equity investment), are the two components of private foreign 
capital, the latter is the predominant and largest components of 
private capital inflows in most of the countries. Markusen and 
Venables (1995) studied that multinational should adopt a general-
equilibrium trade-theoretic view for Foreign Direct Investment.   
The development of foreign private capital are remarkable, but it 
gained importance only after the unmanageable balance of 
payments deficits occurred in most of the developing countries 
after the oil crisis in late seventies; and with the advent of debt 
crisis in Latin American countries in eighties. The Official 
Development Finance (ODF) like the World Bank, International 
Monetary Fund and United Nations which grants loans on 
concessional terms for individual governments, multilateral 
institutions and developing countries to find an alternative strategy 
for reduction in ODF over time.  The importance on non-debt 
creating, long-term private capital to overcome the capital crunch 
situation of developed countries was realized and FDI which falls 
into this category was given due importance. Thus the foreign 
direct investment witnessed dynamic changes over the years and 
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attracted the global investor‟s attention towards investing in 
developing countries like Russia, China, India, Indonesia etc.,  
The present study is specifically focuses on pharma industry in the 
Indian scenario and examines the various measures of financial 
performance and analyzes their profitability position. The 
remainder of the paper is structured as follows. Next section 
presents an overview of pharmaceutical industry.  Section 3 deals 
with earlier literature review pertaining to FDI. Section 4 presents 
the data and methodology, Section 5 examines the empirical 
analysis and discussion of FDI assisted pharmaceutical units. 
Finally, Section 6 summaries and concludes the paper. 
Overview of Pharmaceutical Industry 
Intercontinental Medical Statistics (IMS) Health has broadly 
divided the world pharmaceutical market into six major blocks, 
comprising North America, European Union, Central & Eastern 
Europe, Latin America, Japan and Asia (excluding Japan), 
Australia, & Africa. The USA is the largest drug market in world.  
The other large drug markets are Europe and Japan, each 
pharmaceutical market has its own unique characteristics in terms 
of structure of industry, channels of distribution, protection of 
patents, funding of healthcare costs, etc.  The US generic market is 
nearly 5-6 times of the Indian pharmaceuticals market. This attracts 
a lot of attention and investment in the Indian Industry to cater this 
market.  On account of this universal assumption the US market is 
the most regulated market as compared to the others and may be 
considered the toughest market to succeed for any company. If a 
company manages to establish its presence in the US market, it is 
widely believed that accessing other markets would not be a 
difficult task. 
The Indian pharmaceutical industry had 2000 players in the 
domestic market before 1970 and it was largely dominated by 
multinational companies (MNCs).  The Government of India has 
introduced two landmark regulations in 1970, viz., the Indian 
Patent Act and the Drug Price Control Order (DPCO). The Indian 
Patent Act, 1970 was introduced to encourage domestic producers 
to manufacture drugs and ensure self-sufficiency in medicines. The 
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DPCO governed the prices of all bulk drugs and formulations to 
ensure the widespread availability of medicines at reasonable 
prices. The introduction of these two regulations and incentives 
available to small-scale industries (SSIs) led the share of SSIs 
increasing, due to low entry barriers. Further, owing to 
introduction of FERA 1974, which required all MNCs to dilute their 
equity holding, the market share of MNCs declined during 1970-79. 
During the period 1979 to 1987, the production of bulk drugs by 
Indian players increased due to a surge in exports.  The market 
share of MNCs continued to decline.  In 1991 there was a major 
turning point for MNCs due to the liberalization of Indian 
Economy.   
As part of the reforms process, tariff barriers were lowered and 
FERA was relaxed.  This restored MNC confidence to a certain 
extent and encouraged FDI in the domestic pharmaceutical 
industry. During the period 1987 to 2001, the Indian 
pharmaceutical industry grew faster at a Cumulative Abnormal 
Growth Rate (CAGR) of 15-16 per cent with bulk drug production 
surging due to high export demands. In 1995, the government 
again amended the DPCO and brought down the number of drugs 
under price control to 74%.  Also, the Indian govt. as a member of 
WTO, agreed in 1995 to adhere to the product patent regime from 
2007.  
Brief Literature Review 
To have a better understanding about the performance of select 
Foreign Direct Investment (FDI) some of the research studies 
conducted by matured authors of recent origin.  Blomstrom and 
Zejan (1991), Wheeler and Mody (1992), Serven and Soliman (1992), 
Morck and Young (1992), Burgers et al (1993) present evidence 
about the general aspects of Foreign Direct Investment and 
reported a optimistic sign for the home country production. There 
are few studies experienced the positive effects of foreign direct 
investment in the developing countries.  Lim (1976) pointed out the 
foreign-owned and controlled companies have higher capital 
utilization, because of the technological economies that come with 
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the large size and operation of these firms. Nayyar (1978) stated the 
conflict between the capital and labour within the industrialized 
countries. Kumar (1985), Kokko (1994), Henrik Hansen and John 
Rand (2006) has favoured new technological transfers and adoption 
of new technology for the FDI country. Schneider & Frey (1985), 
Tsai (1991) and Noorbaksh et al. (2001) have studied the 
determinant of FDI in developing countries has performed the best. 
Fry (1993) found that FDI has increased the rate of economic 
growth in the absence of financial repression and trade distortion. 
Muscatelli and Stevenson (1994) study confirms that there is a 
significant role for cross-price effects in Least Developed Countries 
and shows there is efficient gains for the group.  
In contrast, limited research is available on sector – wise foreign 
direct investment performance in India.  Most of the studies related 
to overview of FDI on home country production, determinants of 
FDI and its spill over effect. Only a few studies, has made an 
attempt towards sector-wise performance. Mohinder Kaura and 
Balasubramanian (1982), Muneeswari (2000) studied the drugs and 
pharmaceutical industry in India continued to maintain steady 
growth with foreign collaboration. Sharma Kishor (2000) has 
assessed the effects of FDI on manufacturing export performance. 
Atherye and Kapur (2001) and John Child et al. (2003) studied the 
performance of multinational and domestic firms in India and gave 
clear edge over domestic firms. Ike Mathur Manohar Singh & 
Kimberly C. Gleason (2004) has explained the degree of 
multinational diversification is strongly related to superior 
financial performance and the developing economies continue to 
show dramatic growth. Moreover, this study will fill the gap on 
sector wise performance and paved the way for future researchers. 
Data and Methodology 
The study is based on the secondary data collected from different 
sources for the analysis. Data set has been retrieved from 
Organization of Pharmaceuticals Producers of India (OPPI) and it is 
supported by the annual reports of the companies from CMIE 
Prowess database. The data used in the study consist of 23 Foreign 
Direct Invested pharmaceutical companies with capital as the base 
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during the period from 1st April 1999 to 31st March 2008. The 
following decision making parameters such as Capital Structure 
Ratios, Liquidity Ratios, Profitability Ratios, Ratios of Du Pont 
Analysis and Return on Investment was calculated for the purpose 
of analysis. The computed data is analyzed with the help of Mean, 
Standard Deviation, Co-efficient of Variation and Linear Growth 
Rate was draw for the valid conclusion. 
Evaluating Measures 
Composition of Capital Structure: Capital Structure refers to the way a 
corporation finances itself through some combination of equities, 
bonds, and loans etc.,  A capital structure looks for opportunities 
created by the differential pricing of different instruments issued 
by the same corporation. The long term financial strength measures 
in terms of its ability to pay the interest regularly as well as repay 
the instalment of the principal on due dates from can be examined 
by using leverage of capital structure ratios. Debt equity ratio and 
Debt to asset ratios was worked out to explore the financial 
soundness of the firm. 
Operating Performance of Managing Funds: Liquidity ratios seem to 
have predictive ability, particularly in signalling strengths and 
weakness of a firm in utilization of funds.   These ratios are also 
termed as „working capital ratio‟ or „short term solvency ratios‟.  
An enterprise must have adequate working capital to run its day-
to-day operations.  Inadequacy of working capital may bring the 
entire business operation to a grinding halt because of inability of 
the enterprises to pay for wages, materials and other regular 
expenses. Current ratio and Quick ratios are used to examine the 
liquidity position of the firm. 
Overall Profitability: Profitability is an indicator of the efficiency 
with which the operations of the business are carried on.  Poor 
operational performance may indicate poor sales and hence poor 
profits.  A lower profitability may arise due to the lack of control 
over the expenses.  Bankers, financial institutions and other 
creditors look at the profitability ratios as an indicator whether or 
not the firm earns substantially more than it pays interest for the 
use of borrowed funds and whether the ultimate repayment of 
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their debt appears reasonably certain.  Owners are interested to 
know the profitability as it indicates the return that they can get on 
their investments.   
Overall Efficiency (Du Pont Analysis): Return on Investment (ROE) 
represents the earning power of the company.  ROE depends on 
two ratios: (a) Net Profit ratios, and (b) Capital Turnover Ratios.  A 
change in any of these ratios will change the firm‟s earning power.  
These two ratios are affected by many factors.  A change in any of 
these factors will change these ratios also.  This chart is known as 
the Du Pont Control Chart since it was first used by Du Pont 
Company of USA. 
Here the return on capital employed is affected by a number of 
factors.  Any change in these factors will affect the return on capital 
employed. The chart helps the management in concentrating 
attention on different forces affecting profit.  An increase in profit 
can be achieved either more effective use of capital which will 
result in a higher turnover ratios or better sales efforts which will 
result in a higher turnover ratio or better sales efforts which will 
result in a higher net profit ratio.  The same rate of return can be 
obtained either by a low net profit ratio but a higher turnover ratio 
or low turnover ratio but a higher net profit ratio. 
Return on Investment (ROI): For a given use of money in an 
enterprise, the ROI (return on investment) is how much profit or 
cost saving is realized. An ROI calculation is sometimes used along 
with other approaches to develop a business case for a given 
proposal. The overall ROI for an enterprise is sometimes used as a 
way to grade how well a company is managed. 
It has been observed that although a high profit margin is a test of 
better performance a low margin does not necessarily imply a 
lower rate of return on investments of a form has higher 
investment/assets turnovers. Therefore, the over-all operating 
efficiency of a firm can be assessed on the basis of a combination of 
the investment (RIO) ratio. The earning power of a firm may be 
defined as the over-all profitability of an enterprise.  In reality, 
most organizations use one or more “financial metrics” which they 
refer to individually or collectively as “ROI”.  
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Empirical Analysis and Discussion 
Table: 1 presents the Capital Structure Ratios of Foreign Direct 
invested pharmaceutical units for the period from 1999 to 2008 by 
using two methods such as Debt to Equity Ratios and Debt to Asset 
Ratios. In Debt to equity ratio the Linear Growth Rate (LGR) of FDI 
assisted pharmaceutical units with statistically significant for most 
of the units.  In other ratios the LGR stood rational at 0.05 and 0.01 
for twelve units with statistically significant.  But the remaining 
units showed an insignificant effect during the study period. From 
Table: 2 envisage the liquidity position of the FDI assisted 
pharmaceutical units.  Liquidity ratio was divided into current 
ratio and quick ratios. The LGR of current ratio and quick ratio has 
shown almost significant for all the units. This suggested the 
financial position for all the units with a positive sign.  
The profitability ratios for FDI assisted pharmaceutical units have 
been shown in Table 3. Perusal from the above table indicates the 
trends and growth pattern of Gross Profit margin, Earning Power 
and Return on Assets has been analyzed. In Gross profit margin the 
mean and linear growth rate has shown significant effect.  But, the 
earning power ratio and return on assets for the above units was 
predicted with weak position. This predicted the units have not 
properly utilized the earning power and assets to reap the fruits of 
benefits. It is evident from Table: 4 the trends and growth pattern 
of FDI assisted Pharmaceutical Units. The Du Pont Analysis has 
been broken into three disciplines; Net Profit margin ratio, Asset 
Turnover ratios and Leverage Multiplier ratios. Perusal from the 
table Net profit margin was performed well with significant effect. 
In asset turnover ratios the means return shows a minimum level, 
but in linear growth rate it indicated with negative line for the 
periods. Finally, the Leverage multiplier was not favourable for the 
units; it is due to over utilization of the outsider‟s capitals for 
gearing profits.  
Table 5 envisages the trends and growth of Return on equity (Based 
on Du Pont Analysis) for FDI assisted Pharmaceutical units.   The 
table indicates mean return of Sun Pharma stood higher at 28.37 
per cent. The standard deviation indicates a huge volatile for 
Matrix laboratories and lowers for Wyeth Ltd. In Coefficient of 
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variation Matrix Laboratories and Aurobindo Pharma predicted 
with 410.74 and 14.01 times respectively.  The last row refers to 
Linear Growth rate of FDI assisted pharmaceutical units with 
statistically insignificant for majority of the units during the study 
period. 
Table: 6 show the overall performance of FDI assisted 
pharmaceutical units for the period from 1999 to 2008.  Perusal 
from the table indicates the linear growth rate shown an 
inexperienced negative trend for Capital Structure ratios.  The 
liquidity position of the Company was good for the period.  As far 
as the profitability ratios, the Gross profit Margin suggested a 
healthy sign.  Earning power and Return on assets has been scaled 
up. The results of Profitability Ratios predicted a robust for the 
overall Pharmaceuticals units. The components of ROE, has been 
used in Du Pont Analysis, Net profit margin (NPM), Asset 
Turnover Ratio (ATR) and Leverage Multiplier (LM), was 
experienced and shown a positive movement, but only in the case 
of ATR, the trend has been statistically significant.  Again, this 
reveals the improper use of assets by the units.  Further, return on 
equity, which can be considered as proxy for fund position of the 
company with statistically significant during the period.  
Summary and Conclusion 
This study focuses on performance of selected Foreign Direct 
Invested pharmaceutical units for the period 1st April 1999 to 31st 
March 2008 and it is evaluated through various parameters. During 
the period of study 23 companies has been taken for the purpose of 
analysis.  From the above analysis, it is found that most of the units 
have performed well and shown positive growth.  But, the 
remaining units have proved with downward trend. But this 
insignificant effect is not constant because most of the units was 
been lagging due to improper utilization of the funds.  This can be 
eradicated when proper measures are adopted by the lagging 
concerns. 
The findings of the study suggest the capital has been efficiently 
used in gearing profits.  But, there was a slight decline in return on 
Perumal Sridharan                                                                       ISSN 0975-3311 
86 
 
equity due to over utilization of outsider‟s fund; it was the major 
reason for showing negative effects. The liquidity position and 
short-term solvency positions have improved. The long-term debts 
have decreased because of this sales have escalated, the leverages 
effects are not found favourable.  With reference to mark financial 
evaluation of the FDI assisted units the different ratios report a 
positive direction all through the study period. Finally, the 
structural changes in the present economic policy and out door 
investment will enhance the growth rate of Indian economy in the 
future. 
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